Skip to main content
Caplight Logo









TRAINFES

TRAINFES

Private
SantiagoHealthcare & Life Scienceshttps://www.trainfes.cl/

Last Round

Grant

Jun 22, 2022

Total Funding Raised

$2.94M

Company Overview

TRAINFES operates in Healthcare & Life Sciences and is based in Santiago. Its latest recorded funding round was a Grant round in June 2022.

TRAINFES is a healthtech company that provides a digital neuro-rehabilitation platform and proprietary neuromuscular electrical stimulation devices for individuals with motor paralysis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Medical AI, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

TRAINFES Comparables

Compare TRAINFES with similar companies based on industry and business-model similarity.

TRAINFES comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Restorative Therapies, Inc.
82%
SynPhNe
81%
MYOLYN, Inc.
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

TRAINFES Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 22, 2022
SeedMay 16, 2022
Pre SeedOct 1, 2019
GrantOct 21, 2013
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

TRAINFES Investors

Notable investors and investment history

TRAINFES investors
InvestorRounds
UDD VenturesGrant
InvexorPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 5, 2026

    Monthly visitors grew 56% MoM.

  • Jan 22, 2026

    Monthly visitors grew 475% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

TRAINFES Filings

Explore SEC and related filing metadata, where available.

TRAINFES filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about TRAINFES's valuation, stock price, and market status.

Is TRAINFES a public or private company?

TRAINFES is a private company.

What is the current stock price of TRAINFES?

TRAINFES is a private company, so its shares have no public market price. Caplight tracks TRAINFES's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is TRAINFES worth (valuation)?

Valuation information for TRAINFES is not publicly available.

Can I buy TRAINFES stock?

TRAINFES shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was TRAINFES's last funding round?

TRAINFES's most recent funding round was Grant on June 22, 2022.

Who are the main investors in TRAINFES?

Key investors in TRAINFES include Invexor.

Will TRAINFES IPO soon?

No public IPO plans have been announced for TRAINFES.

How can I track TRAINFES secondary market activity?

Caplight tracks bids, offers, and trades in TRAINFES's shares on secondary markets.

Firmographic Details

HeadquartersSantiago
Employee Range24
Year Founded2013
Last FundingJun 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?